Transcription of Formulation Development, Testing, and Approval
{{id}} {{{paragraph}}}
Formulation development , testing , and Approval Part I of 2. Leon H. Kircik, MD, Joseph B. Bikowski, MD. David E. Cohen, MPH, MD. Zoe Diana Draelos, MD. Adelaide Hebert, MD. March 2010. Ve h i c l e s M a t t e r W elcome to Vehicles Matter, Part I, the first in a two-part series that explores the important role of the vehicle on the efficacy, safety, and tol- erability of a drug Formulation . Starting with the process of Formulation plan- Table of Contents Topical Drug Delivery .. 3. ning through the FDA Approval process, this first edition of Vehicles Matter Penetration Enhancers: elucidates the critical considerations that go into designing a new topical Benefits and challenges .. 6. therapy. In Part II (June 2010), we'll take a closer look at specific drug formula- tions in order to better understand the unique ways that these various prod- Topical Dosage Forms.
Formulation Development, Testing, and Approval Part I of 2 Leon H. Kircik, MD, Joseph B. Bikowski, MD ... ucts address the challenges of formulation to ensure tolerability and efficacy. ... Practical Dermatology will help you make more informed therapeutic deci-
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}